Discovery research and translation science of trastuzumab deruxtecan, from non-clinical study to clinical trial
Abstract
An antibody–drug conjugate (ADC) is a biological drug that binds a drug to a monoclonal antibody via an appropriate linker. ADCs use antibodies to selectively deliver a potent cytotoxic agent to tumor cells, thus drastically improving the therapeutic index of chemotherapeutic agents. We discovered trastuzumab deruxtecan (T-DXd) via study of ADC linker-payload technology that combined a DNA topoisomerase I inhibitor with an anti- human epidermal...
Paper Details
Title
Discovery research and translation science of trastuzumab deruxtecan, from non-clinical study to clinical trial
Published Date
Jan 1, 2021
Volume
3
Issue
2
Pages
65 - 71
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History